Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study
NCT ID: NCT04768634
Last Updated: 2024-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
46 participants
INTERVENTIONAL
2021-03-23
2024-02-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Current practice is to monitor for arrhythmias after cardiac surgery, and to treat them if they occur. With this research, we want to investigate whether we can identify patients who will develop arrhythmia, and treat them before they occur.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Rhytmia System to Determine the Precise Location and Potential Mechanism of Premature Contractions
NCT03460535
Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy
NCT00753233
ATrial Tachycardia PAcing Therapy in Congenital Heart
NCT03209583
Prevention of Atrial Tachycardia After a Right Atriotomy II
NCT00709384
Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
NCT00004773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observation
Patients will be observed for arrhythmias and treated if they occur.
No interventions assigned to this group
Testing
Patients will undergo provocative electrophysiology testing, and antiarrhythmic medication considered if arrhythmias can be induced.
Provocative electrophysiology study
Provocative electrophysiology testing will be performed at the bedside using the temporary pacing wires placed at the time of surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provocative electrophysiology study
Provocative electrophysiology testing will be performed at the bedside using the temporary pacing wires placed at the time of surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients on antiarrhythmic medication at the time of surgery
* Patients with atrioventricular conduction disease (1st degree atrioventricular block with PR interval greater than 200 ms, 2nd degree atrioventricular block or complete heart block)
* Patients with severe ventricular dysfunction in whom therapy with beta-blocker or sotalol is deemed contra-indicated by the primary team
* Patients with absent or non-functioning atrial pacing wires
0 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
The Children's Heart Foundation
OTHER
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Audrey Dionne
Pediatric Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Audrey Dionne, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00037574
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.